2019年

26.

Watanabe J, natsumeda M, kanemaru Y, Okada M, Oishi M, kakita A, Fujii Y (2019) Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma. Leukemia Lymphoma

25.

Sergei A, Takahashi M, Katsuragi Y, Kakihana T, Kitaura H, Zhang L, Kakita A, Fujii M (2019) G3BP1 inhibits ubiquitinated protein aggregations by interacting with p62 and USP10. Sci Rep

24.

Shirozu H, Hashizume A, Masuda H, Kakita A, Otsubo H, Kameyama S (2019) Surgical strategy for focal cortical dysplasia based on the analysis of the spike onset and peak zones on magnetoencephalography. J Neurosurg

23.

Yamada Y, Fukushima T, Kodama S, Shimizu H, Kakita A, Makino K, Sekijima Y (2019) A case of cerebral amyloid angiopathy-type hereditary ATTR amyloidosis with Y69H (p.Y89H) variant displaying transient focal neurological episodes as the main symptom. Amyloid

22.

Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Shimamoto C, Nozaki Y, Hisano Y, Esaki K, Mataga N, Hayashi-Takagi A, Kunii Y, Kakita A, Yabe H, Yoshikawa T (2019) Investigation of betaine as a novel psychotherapyeutic for schizophrenia. EBioMedicine

21.

Suzuki H, Sugano H, Nakajima M, Higo T, Iimura Y, Mitsuhashi T, Fusegi K, Kakita A, Otsubo H, Arai H (2019) The epileptogenic zone in pharmacy-resistant temporal lobe epilepsy with amygdala enlargement. Epileptic Disord 2019; 21 (3): 252-264

20.

Ono CT, Yu Z, Kikuchi Y, Kunii Y, Hino M, Matsumoto J, Nagaoka A, Ito J, Iwasaki Y, Hagihara H, Miyakawa T, Yoshida M, Saito Y, Niwa S, Yabe H, Kakita A, Tomita H (2019) A minimal amount of tissue-based pH measurement to improve quality control in neuropsychiatryic postmortem brain studies. Psychiatry Clin Neurosci

19.

Watanabe J, Natsumeda M, Okada M, Kanemaru Y, Tsukamoto Y, Oishi M, Kakita A, Fujii Y (2019) Podoplanin expression and IDH-wildtype status predicts venous thrombolism in patients with high-grade gliomas in early postoperative period. World Neurosurg

18.

Kon T, Tanji K, Mori F, Kimura A, Kakita A, Wakabayashi K (2019) Immunoreactivity of myelin-associated oligodendrocytic basic protein in Lewy bodies. Neuropathology

17.

Tanji K, Miki Y, Mori F, Kon T, Kakita A, Takahashi H, Wakabayashi K (2019) Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions of multiple system atrophy. Brain Pathology

16.

齋藤 理恵、柿田明美 (2019) a シヌクレイノパチー (2) 多系統萎縮症.  連載 –変性疾患のみかた–. 病理と臨床

15.

Inoue M, Saito R, Kakita A, Tainaka K (2019) Rapid chemical clearing of white matter in post-mortem human brain by 1,2-hexanediol delipidation. Bioorganic Medicinal Chem Lett 29 (15): 1886-1890

14.

Tanji K, Miki Y, Mori F, Nikaido Y, Narita H, Kakita A, Takahashi H, Wakabayashi K (2019) A mouse model of adult-onset multiple system atrophy. Neurobiol Dis 127: 339-349

13.

村松 一洋,清水 宏 (2019) Neurodegeneration with brain iron accumulationの一剖検例.小児神経学の進歩 48: 74-86

12.

Funayama K, Shimizu H, Tanaka H, Kawachi I, Nishino I, Matsui K, Takahashi N, Koyama A,Katsuragi-Go R, Higuchi R, Aoyama T, Watanabe H, Kakita A, Takatsuka H (2019) An autopsy case of peliosis hepatis with X-linked myotubular myopathy. Legal Med (Tokyo) 38: 77-82

11.

他田真理、柿田明美 (2019) II. 各論 1. 多系統萎縮症 C. 病理.非定型パーキンソニズム −基礎と臨床−.下畑享良(編). 文光堂, 東京. pp. 94-99 (total 242 p).

10.

伊藤 陽、吉田浩樹、清水敬三、長谷川まこと、今野公和、中原亜紗、原 範和、宮下哲典、池内 健、豊島靖子、柿田明美 (2019) 統合失調症として長期入院していた特発性基底核石灰化症 (Fahr病) の臨床病理学的特徴.精神医学 61 (5): 595-603.

9.

Matsumura N, Nobusawa S, Ito J, Kakita A, Suzuki H, Fujii Y, Fukuda M, Iwasaki M,Nakasato N, Yominaga T, Natsume A, Mikami Y, Shinojima N, Yamazaki T, Nakazato Y, Hirato J, Yokoo H (2019) Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors. J Neurooncol 143 (1): 27-33

8.

Watanabe J, Matsumeda M, Olada M, Kobayashi D, Kanemaru Y, Tsukamoto Y, Oishi M, Kakita A, Fujii Y (2019) High detection rate of MYD88 mutations in cerebrospinal fluid from patients with central nervous system lymphomas. JCO Precis Oncol e1-e10

7.

Tanaka H, Kawakatsu S, Toyoshima Y, Miura T, Mezaki N, Sanpei K, Kobayashi R, Hayashi H, Otani K, Ikeuchi T, Onodera O, Kakita A, Takahashi H (2019) Globular glial tauopathy type II: clinicpathological study of two autopsy cases. Neuropathology 39 (2): 111-119

6.

Nozawa T, Okada M, Natsumeda M, Eda T, Abe H, Tsukamoto Y, Okamoto K, Oishi M, Takahashi H, Fujii Y, Kakita A (2019) EGFRvIII is expressed in cellular areas of tumor in a subset of glioblastoma. Neurol Med Chir (Tokyo) 59 (3): 89-97

5.

竹腰顕,吉倉延亮,小澤憲司,生駒良和,竹島明,大槻美佳,中道一生,西條政幸,望月清文,柿田明美,下畑享良 (2019) 経過中にBálint症候群を発症し、塩酸メフロキンとミルタザピンの併用療法により改善した進行性多巣性白質脳症の1例. Brain Nerve 71 (3): 281-286

4.

Masaki T, Tsujimoto M, Kitazawa R, Nakano E, Funasaka Y, Ichihashi M, Kitazawa S, Kakita A, Kanda F, Nishigori C (2019) Autopsy findings and clinical feature of a mild-type xeroderma pigmentosum complementation group A siblings: 40 years of follow-up. J Am Acad Dermatol Case Rep 5 (3): 205-208

3.

Saito R, Toyoshima Y, Tanaka H, Nozaki H, Tsubata Y, Morioka T, Horikawa Y, Oyanagi K, Morita T, Nemoto K, Onodera O, Kakita A (2019) Retinal vasculopathy with cerebral leukodystrophy: clinicaopathologic features of a Japanese autopsied patient with a heterozygous TREX1 mutation. J Neuropathol Exp Neurol 78 (2): 181-186

2.

張 璐、田中英智、柿田明美 (2019) 病理所見を理解する基礎 – 海馬硬化 – .てんかんをわかり易く理解するための神経科学.てんかん研究 39 (3): 664-666

1.

北浦弘樹、柿田明美 (2019) AMPA型グルタミン酸受容体の構造とシナプス伝達機構.ペランパネルによるてんかんの治療ストラテジー.加藤天美(編集).pp. 17-21. (total 89 p). 先端医学社